Literature DB >> 20369146

Update in inflammatory bowel disease.

Graham Morrison1, Belinda Headon, Peter Gibson.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is a common disease in Australia and frequently encountered in primary care. Major developments in investigation and management have taken place.
OBJECTIVE: This article aims to review some recent breakthroughs in IBD investigation and management. DISCUSSION: Diagnosis involves a changing combination of enhanced traditional techniques with new diagnostic tools, typically blood and stool testing with improved endoscopy and new radiological tests. Management has seen the introduction of new powerful biologic therapies, greater understanding in the way we use older therapies, and a focus on preventing complications such as malignancy or infection. Treatment philosophy now attempts to alter the natural history of the disease and prevent long term complications. The importance of associated, previously overlooked factors is being increasingly recognised. Only by taking a long term, patient centred multidisciplinary approach will an optimal outlook for the majority of patients with IBD be achieved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20369146

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  13 in total

1.  Periplaneta americana extract ameliorates dextran sulfate sodium-induced ulcerative colitis via immunoregulatory and PI3K/AKT/NF-κB signaling pathways.

Authors:  Lianli Ni; Qian Lu; Miao Tang; Lu Tao; Hairong Zhao; Chenggui Zhang; Yun Yu; Xiumei Wu; Heng Liu; Ri Cui
Journal:  Inflammopharmacology       Date:  2022-03-18       Impact factor: 4.473

2.  Role of the IL-23-T-bet/GATA3 Axis for the Pathogenesis of Ulcerative Colitis.

Authors:  Haruei Ogino; Keita Fukaura; Yoichiro Iboshi; Yousuke Nagamatsu; Hiroaki Okuno; Kei Nishioka; Yuichiro Nishihara; Yoshimasa Tanaka; Takatoshi Chinen; Eikich Ihara; Yoshihiro Ogawa
Journal:  Inflammation       Date:  2020-10-10       Impact factor: 4.092

Review 3.  Therapeutic implications of inflammasome in inflammatory bowel disease.

Authors:  Vishal Khatri; Ramaswamy Kalyanasundaram
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

Review 4.  Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides.

Authors:  Kazuo Azuma; Tomohiro Osaki; Saburo Minami; Yoshiharu Okamoto
Journal:  J Funct Biomater       Date:  2015-01-14

5.  KIF9‑AS1, LINC01272 and DIO3OS lncRNAs as novel biomarkers for inflammatory bowel disease.

Authors:  Sen Wang; Yong Hou; Weiping Chen; Jianmin Wang; Weihua Xie; Xiaoping Zhang; Li Zeng
Journal:  Mol Med Rep       Date:  2017-11-20       Impact factor: 2.952

6.  Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation.

Authors:  Luiz Domingues Almeida Junior; Ana Elisa Valencise Quaglio; Celso Acácio Rodrigues de Almeida Costa; Luiz Claudio Di Stasi
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

7.  Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice.

Authors:  Lu Chen; Zhongyin Zhou; Yan Yang; Na Chen; Hongyu Xiang
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

8.  Pharmacists' Confidence in Managing Patients with Inflammatory Bowel Disease.

Authors:  Sharmila S Prasad; Simon Keely; Nicholas J Talley; Therése Kairuz; Marjorie M Walker
Journal:  Pharmacy (Basel)       Date:  2020-04-17

Review 9.  The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases.

Authors:  Aristofanis Gikas; John K Triantafillidis
Journal:  Int J Gen Med       Date:  2014-03-13

10.  The murine appendiceal microbiome is altered in spontaneous colitis and its pathological progression.

Authors:  Sultan Alkadhi; Dale Kunde; Rajkumar Cheluvappa; Sarron Randall-Demllo; Rajaraman Eri
Journal:  Gut Pathog       Date:  2014-06-21       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.